Hb EP

Hemoglobin Electrophoresis

Großes Blutbild

Zuletzt geprüft: 7. April 2026. Quellenansatz: Standardkontext zur Laborinterpretation, allgemeine medizinische Referenzmaterialien sowie öffentliche Gesundheits- oder klinische Leitlinien, sofern relevant.

Was ist Hemoglobin Electrophoresis?

Hemoglobin electrophoresis is a laboratory technique that separates and identifies different types of hemoglobin in a blood sample based on their electrical charge and mobility in an electric field. Normal adult blood contains primarily hemoglobin A (HbA, approximately 95–98%), with small amounts of hemoglobin A2 (HbA2, 2–3.5%) and hemoglobin F (HbF, <2%). Hemoglobin electrophoresis, along with complementary methods such as high-performance liquid chromatography (HPLC) and capillary electrophoresis, can detect abnormal hemoglobin variants (HbS, HbC, HbE, HbD, and others) and quantify the proportion of each hemoglobin type present.

This test is the definitive diagnostic tool for hemoglobinopathies—inherited disorders of hemoglobin structure or production. Hemoglobinopathies include structural variants (such as sickle cell disease caused by HbS and HbC disease) and thalassemias (characterized by reduced production of normal globin chains leading to elevated HbA2 or HbF). These are among the most common genetic disorders worldwide, with approximately 5% of the global population carrying a significant hemoglobin variant. Hemoglobin electrophoresis is used for diagnostic confirmation, newborn screening follow-up, carrier identification, and prenatal genetic counseling.

Warum der Wert wichtig ist

Hemoglobin electrophoresis is essential for diagnosing sickle cell disease, thalassemia syndromes, and other hemoglobinopathies that collectively affect millions of people worldwide. In sickle cell disease (HbSS), identifying the hemoglobin pattern guides treatment decisions including hydroxyurea therapy, transfusion protocols, and eligibility for curative gene therapy or bone marrow transplant. In thalassemia, elevated HbA2 (>3.5%) is the hallmark of beta-thalassemia trait, while elevated HbF characterizes beta-thalassemia major/intermedia and hereditary persistence of fetal hemoglobin. Carrier identification is critical for genetic counseling—two carriers of sickle cell trait (HbAS) have a 25% chance of having a child with sickle cell disease with each pregnancy.

Normale Referenzbereiche

GruppeBereichEinheit
Hemoglobin A (HbA)95–98%
Hemoglobin A2 (HbA2)2.0–3.5%
Hemoglobin F (HbF)<2%
Hemoglobin S (HbS)0%
Hemoglobin C (HbC)0%

Referenzbereiche können je nach Labor variieren. Vergleichen Sie Ihre Ergebnisse immer mit den Bereichen Ihres Testlabors.

Was hohe Hb EP-Werte bedeuten

Häufige Ursachen

  • Elevated HbA2 (>3.5%): beta-thalassemia trait, megaloblastic anemia, hyperthyroidism
  • Elevated HbF (>2%): beta-thalassemia major/intermedia, sickle cell disease (especially on hydroxyurea), hereditary persistence of fetal hemoglobin (HPFH), myelodysplastic syndromes
  • Presence of HbS: sickle cell disease (HbSS: 80–95% HbS) or sickle cell trait (HbAS: 35–45% HbS)
  • Presence of HbC: HbC disease (HbCC) or HbC trait (HbAC)
  • Presence of HbE: HbE disease or HbE/beta-thalassemia (common in Southeast Asia)

Mögliche Symptome

  • Sickle cell disease: pain crises, anemia, fatigue, jaundice, splenic sequestration, stroke, acute chest syndrome
  • Beta-thalassemia major: severe anemia, failure to thrive, hepatosplenomegaly, skeletal deformities
  • Beta-thalassemia trait: usually asymptomatic with mild microcytic anemia
  • Sickle cell trait: usually asymptomatic; rare complications under extreme conditions
  • HbC disease: mild hemolytic anemia, splenomegaly

Was zu tun ist: Management depends on the specific hemoglobinopathy identified. Sickle cell disease requires comprehensive care including hydroxyurea (which increases HbF), pain management, infection prophylaxis, screening for organ damage, and potentially curative therapies (stem cell transplant, gene therapy). Beta-thalassemia major requires regular transfusions and iron chelation. Carriers (trait) require genetic counseling for family planning. All patients with significant hemoglobinopathies should be followed by a hematologist.

Was niedrige Hb EP-Werte bedeuten

Häufige Ursachen

  • Decreased HbA: beta-thalassemia (reduced beta-globin production), hemoglobinopathies replacing HbA with variant hemoglobin
  • Low HbA2 (<2%): iron deficiency (can mask thalassemia trait), alpha-thalassemia, HbH disease

Mögliche Symptome

  • Symptoms depend on severity and type of hemoglobinopathy
  • Iron-deficient thalassemia trait may present with microcytic anemia unresponsive to iron

Was zu tun ist: Decreased HbA with increased abnormal hemoglobins confirms a hemoglobinopathy—the specific pattern determines diagnosis and management. If HbA2 is low and iron deficiency is present, correct the iron deficiency first and repeat hemoglobin electrophoresis, as iron deficiency can suppress HbA2 and mask beta-thalassemia trait. For suspected alpha-thalassemia (which may have a normal electrophoresis in adults), molecular genetic testing for alpha-globin gene deletions is needed.

Wann wird ein Hb EP-Test empfohlen?

  • As follow-up to an abnormal newborn hemoglobin screen
  • When evaluating unexplained microcytic anemia that does not respond to iron therapy
  • For carrier screening before or during pregnancy, particularly in high-risk populations
  • When sickle cell disease or trait is suspected
  • To confirm a diagnosis of thalassemia
  • When a family member has a known hemoglobinopathy

Häufig gestellte Fragen

Sickle cell disease (most commonly HbSS) occurs when a person inherits two copies of the sickle hemoglobin gene (one from each parent). On electrophoresis, HbS comprises 80–95% of hemoglobin, with the remainder being HbF and HbA2. These individuals experience chronic hemolytic anemia, pain crises, and organ damage. Sickle cell trait (HbAS) occurs when a person inherits one sickle gene and one normal gene—electrophoresis shows 55–60% HbA and 35–45% HbS. Trait carriers are generally healthy but can pass the gene to children.
Yes. Iron deficiency can lower HbA2 levels, potentially masking beta-thalassemia trait where HbA2 would otherwise be elevated above 3.5%. If you have microcytic anemia and your doctor suspects both iron deficiency and thalassemia, iron stores should be replenished first, followed by repeat hemoglobin electrophoresis for accurate interpretation. This is particularly important for carrier screening during pregnancy.
Newborn screening identifies sickle cell disease and other severe hemoglobinopathies before symptoms develop, enabling early interventions that dramatically improve survival. Before universal screening, many children with sickle cell disease died from overwhelming pneumococcal sepsis in early childhood. Early identification allows prophylactic penicillin starting at 2 months, pneumococcal vaccination, parental education on splenic sequestration, and early enrollment in comprehensive sickle cell programs. Newborn hemoglobin patterns differ from adults because HbF is predominant at birth.

Verwandte Biomarker

HgbHämoglobinMCVMittleres korpuskuläres VolumenMCHMittleres korpuskuläres HämoglobinFeSerumeisenFerritinFerritin

Quellen- und Prüfungsansatz

Biomarker-Glossarseiten sind erklärende Bildungsinhalte und sollten immer zusammen mit den Referenzbereichen und Kommentaren Ihres Labors sowie Ihrer Ärztin oder Ihres Arztes interpretiert werden. Mehr zu unseren redaktionellen Standards und unserem Prüfprozess finden Sie in unserer Redaktionsrichtlinie und Prüfprozess für Inhalte.

Möchten Sie Ihre Hb EP-Werte analysieren lassen?

Laden Sie Ihre Laborwerte hoch und erhalten Sie sofort eine KI-gestützte Einordnung aller Biomarker.

Laborwerte hochladen →

Medizinischer Hinweis: Diese Informationen dienen nur Bildungszwecken und ersetzen keine professionelle medizinische Beratung, Diagnose oder Behandlung. Referenzbereiche können zwischen Laboren variieren. Besprechen Sie die Interpretation Ihrer konkreten Testergebnisse immer mit Ihrer medizinischen Fachperson.

Hinweis: SymptomGPT ist kein medizinisches Diagnosetool und ersetzt keine medizinische Beratung. Wenden Sie sich immer an qualifiziertes medizinisches Fachpersonal. Wenn Sie einen medizinischen Notfall haben, rufen Sie sofort Ihre örtliche Notrufnummer an.